Navigation Links
Chakshu Research Announces Appointment of Dr. Randall Olson as Director
Date:2/11/2008

LOS GATOS, Calif., Feb. 11 /PRNewswire/ -- Chakshu Research, a specialty pharmaceutical company targeted at developing a non-surgical treatment for cataract and other degenerative ocular diseases, announced the addition of Dr. Randall J. Olson, M.D., to its Board of Directors in October of 2007.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080211/AQM073ALOGO)

Dr. Olson is the CEO of the John A. Moran Eye Center and serves as the Chairman of the Department of Ophthalmology and Visual Sciences at the University of Utah. The department is recognized internationally for its research on the complications associated with intraocular lenses.

Dr. Olson was fascinated with Chakshu's early results and wanted to help bring the clinical science to a level of some clarity regarding the potential impact on cataract formation associated with aging. "With proven safety and continued good efficacy trends, Chakshu stands to be the first to offer a non-surgical cataract treatment for such an unmet medical need. Because of this and their trending toward potential treatment for other common eye diseases, I am committed to working with them in hopes of providing additional care for today's unserved patients."

He is the author of more than 300 professional publications and a worldwide lecturer. In addition to specializing in research dealing with intraocular lens complications, Dr. Olson also specializes in teleophthalmology and corneal transplantation techniques. He was selected as one of the 15 best cataract surgeons in the United States in a peer survey conducted by Ophthalmology Times. Cataract and Refractive Surgery Today named Dr. Olson as one of 50 international opinion leaders. He has appeared in the last three editions of Best Doctors in America.

After completing his undergraduate training and medical schooling at the University of Utah (BA '70, MD '73), he completed his residency at UCLA's Jules Stein Eye Institute in 1977. He went on to complete fellowships in cornea and external disease at the University of Florida in Gainesville and at the LSU Eye Center in New Orleans, where he joined the faculty in 1977 as Director of Corneal Services.

Dr. Olson joined the University of Utah faculty as an associate professor and division chief in 1979.

About Chakshu Research

Chakshu Research is a specialty pharmaceutical company committed to discovering treatments for degenerative ocular diseases. They have developed a topical drug, C-KAD Ophthalmic Solution (C-KAD OS), targeted to reduce and repair oxidative damage which has been implicated in blinding degenerative diseases such as cataract, glaucoma, dry AMD, diabetic retinopathy and uveitis. The company is currently in clinical trials for cataract and glaucoma.

http://www.chakshu.com


'/>"/>
SOURCE Chakshu Research
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
2. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
3. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
4. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
5. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
6. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
7. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
8. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
9. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
10. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
11. Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Ginkgo Bioworks , a leading organism design company ... as one of the World Economic Forum,s Technology ... companies. Ginkgo Bioworks is engineering biology to manufacture ... the nutrition, health and consumer goods sectors. The ... Fortune 500 companies to design microbes for their ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... WI (PRWEB) , ... June 23, 2016 , ... ... supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, into ... for over 35 years, is proud to add Target to its list of ...
(Date:6/23/2016)... SILVER SPRING, Md. , June 23, 2016 ... evidence collected from the crime scene to track the criminal ... sick, and the U.S. Food and Drug Administration (FDA) uses ... Sound far-fetched? It,s not. ... whole genome sequencing to support investigations of foodborne illnesses. Put ...
Breaking Biology Technology:
(Date:6/16/2016)... The global Biometric ... USD 1.83 billion by 2024, according to a ... proliferation and increasing demand in commercial buildings, consumer ... the market growth.      (Logo: ... of advanced multimodal techniques for biometric authentication and ...
(Date:6/9/2016)... Paris Police Prefecture and ... ensure the safety of people and operations in several locations ... Teleste, an international technology group specialised in broadband ... its video security solution will be utilised by ... across the country. The system roll-out is scheduled for the ...
(Date:6/2/2016)... 2, 2016 The Department of Transport ... the 44 million US Dollar project, for the , ... including Personalization, Enrolment, and IT Infrastructure , to ... production and implementation of Identity Management Solutions. Numerous renowned international ... Decatur was selected for the most compliant ...
Breaking Biology News(10 mins):